Acelyrin Inc (NASDAQ:SLRN) has a beta value of 1.96 and has seen 6.28 million shares traded in the recent trading session. The company, currently valued at $235.65M, closed the recent trade at $2.35 per share which meant it lost -$1.14 on the day or -32.70% during that session. The SLRN stock price is -278.3% off its 52-week high price of $8.89 and -29.79% below the 52-week low of $3.05. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.76 million shares traded. The 3-month trading volume is 666.50K shares.
The consensus among analysts is that Acelyrin Inc (SLRN) is Buy stock at the moment, with a recommendation rating of 1.86. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 5 out of 14 have rated it as a Hold, with 9 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -0.74.
Acelyrin Inc (NASDAQ:SLRN) trade information
Sporting -32.70% in the red today, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the SLRN stock price touched $2.35 or saw a rise of 40.51%. Year-to-date, Acelyrin Inc shares have moved -25.20%, while the 5-day performance has seen it change -23.74%. Over the past 30 days, the shares of Acelyrin Inc (NASDAQ:SLRN) have changed -44.21%. Short interest in the company has seen 5.99 million shares shorted with days to cover at 8.32.
Wall Street analysts have a consensus price target for the stock at $10.5, which means that the shares’ value could jump 77.62% from the levels at last check today.. The projected low price target is $6.0 while the price target rests at a high of $15.0. In that case, then, we find that the latest price level in today’s session is -538.3% off the targeted high while a plunge would see the stock gain -155.32% from the levels at last check today..
Acelyrin Inc (SLRN) estimates and forecasts
Figures show that Acelyrin Inc shares have outperformed across the wider relevant industry. The company’s shares have lost -53.95% over the past 6 months, with this year growth rate of 52.67%, compared to 16.90% for the industry. Revenue growth from the last financial year stood is estimated to be 0.00%.
SLRN Dividends
Acelyrin Inc is expected to release its next earnings report in February this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Acelyrin Inc (NASDAQ:SLRN)’s Major holders
Insiders own 8.03% of the company shares, while shares held by institutions stand at 99.44% with a share float percentage of 108.12%. Investors are also buoyed by the number of investors in a company, with Acelyrin Inc having a total of 171.0 institutions that hold shares in the company.
